---
title: "DC 6208 - Malignant neoplasm of the ear (other than skin only)"
diagnostic_code: "6208"
body_system: "Impairment of Auditory Acuity"
cfr_section: "§ 4.87"
canonical: "https://veteranai.co/va-rating-schedule/hearing/6208-malignant-neoplasm-of-the-ear-other-than-skin-only"
source: "https://www.ecfr.gov/current/title-38/section-4.87"
updated: "2026-07-21T03:21:44.864374Z"
---

# DC 6208 - Malignant neoplasm of the ear (other than skin only)

Rated under § 4.87. Body system: Impairment of Auditory Acuity.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Malignant neoplasm of the ear (other than skin only) |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, radiation treatment, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based on that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

# Malignant Neoplasm of the Ear (Other Than Skin Only) — VA Diagnostic Code 6208

## Understanding This Condition

**Diagnostic Code 6208** covers a **malignant neoplasm of the ear (other than skin only)** — a cancerous growth involving the ear. The VA evaluates this condition under **§ 4.87**, which falls within the body system for **Impairment of Auditory Acuity**.

## Available Rating Level

Under this diagnostic code, there is a single rating level:

| Rating | Criteria |
| --- | --- |
| **100%** | Malignant neoplasm of the ear (other than skin only) |

## What the VA Looks For

The VA assigns a **100 percent rating** for a malignant neoplasm of the ear (other than skin only).

According to the regulation's note, this 100 percent rating **continues beyond the cessation of any surgical, radiation treatment, antineoplastic chemotherapy, or other therapeutic procedure.**

Key points from the VA's note on this condition:

- **Six months after discontinuance** of such treatment, the appropriate disability rating is determined by a **mandatory VA examination.**
- Any change in evaluation based on that examination — or any subsequent examination — is **subject to the provisions of § 3.105(e).**
- **If there has been no local recurrence or metastasis,** the condition is rated on its **residuals.**

---

*This overview is drawn directly from the VA rating schedule under 38 CFR § 4.87, Diagnostic Code 6208. It is provided for general informational purposes and does not guarantee any particular rating outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.87